Lung Monitors & Screeners
COPD Screeners: The copd-6 identifies those at risk of COPD at the pre-symptomatic stage to allow early medical intervention and facilitate better clinical outcomes. This pioneering device screens out those whose FEV1 is normal, and who therefore do not have COPD, without the risk of false COPD negatives, allowing spirometry resources to be focused on those most at risk. More information can be found here.
Lung Monitor: This easy to use home monitoring device is designed to record key lung function parameters for those with chronic respiratory conditions including cystic fibrosis and transplant patients. More information can be found here.
Smoking Intervention: Smoking is attributed as the main cause of COPD (Chronic Obstructive Pulmonary Disease). COPD is often undiagnosed and untreated in its early stages, especially in smokers. A key indicator of COPD is a reduced FEV1 compared with predicted FEV1 value. Early identification of a reduction in FEV1 can provide early warning of the damage already suffered by the lungs at the pre-symptomatic stage, when smoking cessation is most effective. The Vitalograph lung age compares a subject's FEV1 with predicted normal values to calculate the subject's 'lung age'. A high lung age in relation to the subject's chronological age can illustrate the likely negative impact of continued smoking on lung function and encourage smoking cessation. More information can be found here.